Article
Mesenchymal MAPKAPK2/HSP27 drives intestinal carcinogenesis
29 May 2018
Abstract excerpt
mouse model. Notably, this function of MK2 was not mediated by its well-described immunomodulatory role in immune cells. Deletion of MK2 in intestinal mesenchymal cells (IMCs) led to both reduced tumor multiplicity and growth. Mechanistically, MK2 in IMCs was required for Hsp27 phosphorylation and the production of downstream tumorigenic effector molecules, dominantly affecting epithelial proliferation,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
